{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:09:57Z","timestamp":1781629797602,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Padjadjaran"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Children with\n                    <jats:italic>Multisystem Inflammatory Syndrome in Children (MIS-C)<\/jats:italic>\n                    often have weakened immune systems and more prone to secondary infections such as tuberculosis (TB).\n                    <jats:italic>MIS-C<\/jats:italic>\n                    is a rare case but serious complication of COVID-19. It commonly affects the gastrointestinal, cardiovascular, hematologic, and mucocutaneous systems. This study presents a case of MIS-C in a 15-year-old girl complicated by respiratory failure, increased intracranial pressure with status epilepticus, grade II TB meningitis, severe dengue, disseminated TB, anti-tuberculosis drug induced hepatotoxicity, and cutaneous drug eruption. The patient had a history of prior COVID-19 infections and arrived the emergency department with high fever, loss of consciousness, seizure, a generalized maculopapular rash, and respiratory failure. Laboratory results showed significantly elevated liver enzyme, while chest X-ray confirmed pleural effusion and pulmonary TB. A multidisciplinary team was formed, including specialists in respirology, cardiology, pediatric neurology, immunology, and gastro-hepatology division. The patient received high dose of steroid, anti-tuberculosis regiment, and phenobarbital to control the seizure. N-acetylcysteine and enoxaparin were administered as a part of the MIS-C treatment protocol. The patient was discharged after three weeks of intensive care but required monthly readmission due to recurrent complications. This study suggests the importance of early detection and comprehensive management of MIS-C to reduce the risk of mortality and secondary infection in long-term impact of the syndrome.\n                  <\/jats:p>","DOI":"10.1186\/s12879-026-12514-4","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T11:45:41Z","timestamp":1767959141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A rare case of unusual anti-tuberculosis drug reaction in disseminated tuberculosis with pre-existing Multisystem Inflammatory Syndrome in Children (MIS-C)"],"prefix":"10.1186","volume":"26","author":[{"given":"Riyadi","family":"Adrizain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dyah Ayu Shinta","family":"Lesmanawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadila Dyah Trie","family":"Utami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anggraini","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djatnika","family":"Setiabudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"12514_CR1","unstructured":"COVID-19 cases | WHO COVID-19 dashboard. Accessed September 17. 2025. https:\/\/data.who.int\/dashboards\/covid19\/cases."},{"key":"12514_CR2","unstructured":"COVID-19 and Children in Indonesia COVID-19 and Children in Indonesia An Agenda for Action to Address Socio-Economic Challenges. Published online 2020. Accessed June 13, 2025. https:\/\/www.unicef.org\/press-releases\/un-launches-global-."},{"key":"12514_CR3","doi-asserted-by":"publisher","unstructured":"Putri ND, Prawira Y, Tartila T, et al. Clinical features of multisystem inflammatory syndrome in children associated with COVID-19 in Indonesia. J Trop Pediatr. 2022;68(3). https:\/\/doi.org\/10.1093\/TROPEJ\/FMAC025.","DOI":"10.1093\/TROPEJ\/FMAC025"},{"issue":"11","key":"12514_CR4","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/ARCHDISCHILD-2020-319554","volume":"105","author":"M White","year":"2020","unstructured":"White M, Tiesman B, Handforth J, Kenny J. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): the Evelina experience. Arch Dis Child. 2020;105(11):1025\u20137. https:\/\/doi.org\/10.1136\/ARCHDISCHILD-2020-319554.","journal-title":"Arch Dis Child"},{"key":"12514_CR5","unstructured":"Multisystem inflammatory syndrome in children and adolescents with COVID-19. Accessed June 13. 2025. https:\/\/www.who.int\/publications\/i\/item\/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19."},{"key":"12514_CR6","unstructured":"Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection 2023 Case Definition | CDC. Accessed June 13. 2025. https:\/\/ndc.services.cdc.gov\/case-definitions\/multisystem-inflammatory-syndrome-in-children-mis-c-2023\/."},{"key":"12514_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.prrv.2020.08.001","volume":"38","author":"T Radia","year":"2021","unstructured":"Radia T, Williams N, Agrawal P, et al. Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr Respir Rev. 2021;38:51\u20137. https:\/\/doi.org\/10.1016\/j.prrv.2020.08.001.","journal-title":"Paediatr Respir Rev"},{"key":"12514_CR8","unstructured":"COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis - UpToDate. Accessed June 13. 2025. https:\/\/www.uptodate.com\/contents\/covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-clinical-features-evaluation-and-diagnosis"},{"key":"12514_CR9","doi-asserted-by":"publisher","unstructured":"Somasetia DH, Malahayati TT, Andriyani FM, Setiabudi D, Nataprawira HM. A fatal course of multiple inflammatory syndrome in children coinfection with dengue. A case report from Indonesia. IDCases. 2020;22. https:\/\/doi.org\/10.1016\/j.idcr.2020.e01002.","DOI":"10.1016\/j.idcr.2020.e01002"},{"key":"12514_CR10","doi-asserted-by":"publisher","first-page":"7811891","DOI":"10.1155\/2022\/7811891","volume":"2022","author":"T Piloya","year":"2022","unstructured":"Piloya T, Nakiyingi L, Kimuli I, et al. SARS-CoV-2-Associated multisystem inflammatory syndrome in a child in uganda: A paediatric experience in a Resource-Limited setting. Case Rep Infect Dis. 2022;2022:7811891. https:\/\/doi.org\/10.1155\/2022\/7811891.","journal-title":"Case Rep Infect Dis"},{"issue":"3","key":"12514_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/S00296-021-05030-Y","volume":"42","author":"NK Bagri","year":"2022","unstructured":"Bagri NK, Deepak RK, Meena S, et al. Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study. Rheumatol Int. 2022;42(3):477\u201384. https:\/\/doi.org\/10.1007\/S00296-021-05030-Y.","journal-title":"Rheumatol Int"},{"issue":"2","key":"12514_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/S40124-022-00264-1","volume":"10","author":"L Jiang","year":"2022","unstructured":"Jiang L, Tang K, Irfan O, Li X, Zhang E, Bhutta Z, Epidemiology. Clinical Features, and outcomes of multisystem inflammatory syndrome in children (MIS-C) and Adolescents\u2014a live systematic review and Meta-analysis. Curr Pediatr Rep. 2022;10(2):19\u201330. https:\/\/doi.org\/10.1007\/S40124-022-00264-1.","journal-title":"Curr Pediatr Rep"},{"issue":"2","key":"12514_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/J.IJTB.2020.02.004","volume":"67","author":"S Yasri","year":"2020","unstructured":"Yasri S, Wiwanitkit V. Tuberculosis and novel Wuhan coronavirus infection: pathological interrelationship. Indian J Tuberc. 2020;67(2):264. https:\/\/doi.org\/10.1016\/J.IJTB.2020.02.004.","journal-title":"Indian J Tuberc"},{"issue":"4","key":"12514_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMOA2021756","volume":"383","author":"EM Dufort","year":"2020","unstructured":"Dufort EM, Koumans EH, Chow EJ, et al. Multisystem inflammatory syndrome in children in new York state. N Engl J Med. 2020;383(4):347\u201358. https:\/\/doi.org\/10.1056\/NEJMOA2021756.","journal-title":"N Engl J Med"},{"key":"12514_CR15","doi-asserted-by":"publisher","unstructured":"Rojas FY, Rojas FY. Multisystem inflammatory syndrome in children (MIS-C). Post COVID-19 - Effects on human health. Published Online March. 2023;25. https:\/\/doi.org\/10.5772\/INTECHOPEN.110684.","DOI":"10.5772\/INTECHOPEN.110684"},{"issue":"2","key":"12514_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S2352-4642(20)30304-7","volume":"5","author":"R Harwood","year":"2021","unstructured":"Harwood R, Allin B, Jones CE, et al. A National consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a National Delphi process. Lancet Child Adolesc Health. 2021;5(2):133\u201341. https:\/\/doi.org\/10.1016\/S2352-4642(20)30304-7.","journal-title":"Lancet Child Adolesc Health"},{"key":"12514_CR17","doi-asserted-by":"publisher","unstructured":"Tamuzi JL, Ayele BT, Shumba CS, et al. Implications of COVID-19 in high burden countries for HIV\/TB: A systematic review of evidence. BMC Infect Dis. 2020;20(1). https:\/\/doi.org\/10.1186\/S12879-020-05450-4.","DOI":"10.1186\/S12879-020-05450-4"},{"issue":"4","key":"12514_CR18","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.immuni.2020.07.026","volume":"53","author":"R Zhou","year":"2020","unstructured":"Zhou R, To KKW, Wong YC, et al. Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses. Immunity. 2020;53(4):864\u2013e8775. https:\/\/doi.org\/10.1016\/j.immuni.2020.07.026.","journal-title":"Immunity"},{"issue":"7","key":"12514_CR19","doi-asserted-by":"publisher","first-page":"506","DOI":"10.5588\/IJTLD.23.0078","volume":"27","author":"KP Singh","year":"2023","unstructured":"Singh KP, Carvalho ACC, Centis R, et al. Clinical standards for the management of adverse effects during treatment for TB. Int J Tuberculosis Lung Disease. 2023;27(7):506\u201319. https:\/\/doi.org\/10.5588\/IJTLD.23.0078.","journal-title":"Int J Tuberculosis Lung Disease"},{"issue":"3","key":"12514_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/CEA.14104","volume":"52","author":"S Tan","year":"2022","unstructured":"Tan S, Thong BYH. Anti-tuberculous drug allergy: diagnostic challenges. Clin Exp Allergy. 2022;52(3):370\u20131. https:\/\/doi.org\/10.1111\/CEA.14104.","journal-title":"Clin Exp Allergy"},{"key":"12514_CR21","doi-asserted-by":"publisher","unstructured":"Lam J, Tavares E, Luk SO. Outcomes with enoxaparin dose reductions during thrombocytopenia in patients with hematopoietic stem cell transplantation (HSCT). J Oncol Pharm Pract. 2021;27(6):1364-70. https:\/\/doi.org\/10.1177\/1078155220957747.","DOI":"10.1177\/1078155220957747"},{"key":"12514_CR22","doi-asserted-by":"publisher","unstructured":"Padayachee N, Schoeman N, Schellack N. Enoxaparin. S A Pharm J. 2023;88:26\u20139. https:\/\/doi.org\/10.3109\/9780203492079-64.","DOI":"10.3109\/9780203492079-64"},{"key":"12514_CR23","doi-asserted-by":"publisher","unstructured":"Singh KP, Carvalho ACC, Centis R, D\u2019Ambrosio L, Migliori GB, Mpagama SG, et al. Clinical standards for the management of adverse effects during treatment for TB. Int J Tuberculosis Lung Disease. 2023;27:506\u201319. https:\/\/doi.org\/10.5588\/IJTLD.23.0078.","DOI":"10.5588\/IJTLD.23.0078"},{"key":"12514_CR24","doi-asserted-by":"publisher","unstructured":"Tan S, Thong BYH. Anti-tuberculous drug allergy: diagnostic challenges. Clin Exp Allergy. 2022;52:370\u20131. https:\/\/doi.org\/10.1111\/CEA.14104.","DOI":"10.1111\/CEA.14104"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12514-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12514-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12514-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:31:23Z","timestamp":1781627483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12514-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12514"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12514-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"Written consent was obtained from the patient\u2019s parent for publication this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"285"}}